Prevention of heart failure with chlorthalidone in allhat: Placing the results into perspective

Journal of Clinical Hypertension

Volumn 11, Issue 9, 2009, Pages 462-465

  Massie, Barry M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; PERINDOPRIL; THIAZIDE DIURETIC AGENT; DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MARKETING; EDEMA; EDITORIAL; FLUID RETENTION; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIDE EFFECT; STROKE; SURVIVAL TIME; SYSTOLIC HYPERTENSION; COMPLICATION;

ANTIHYPERTENSIVE AGENTS; CHLORTHALIDONE; DIURETICS; HEART FAILURE; HUMANS; HYPERTENSION; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 70349972044     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00169.x     Document Type: Editorial

References (15)

1. Davis BR, Piller Linda B, Cutler JA. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2006, 113:2201-2210.
2. Einhorn PT, Davis BR, Massie BM. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure validation study: diagnosis and prognosis. Am Heart J 2007, 153:42-53.
3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685-691.
4. Arnold JMO, Yusuf S, Young J. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003, 107:1284-1290.
5. Grimm RH, Davis BR, Piller LB. Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?. J Clin Hypertens (Greenwich) 2009, 11:xxx-xxx. for the ALHATT Collaborative Research Group
6. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs Diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981-2997.
7. Diuretic versus α-blocker as first-step antihypertensive therapy. Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2003, 42:239-246.
8. Psaty BM, Lumley T, Furberg CD. Health outcomes associated with various antihypertensive therapies used as first line agents: a network meta-analysis. JAMA 2003, 289:2534-2544.
9. Davis BR, Kostis JB, Simpson LM. Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2008, 118:2259-2267.
10. Cutler JA, Davis BR. Thiazide-type diuretics and β-adrenergic blockers as first-line drug treatments for hypertension. Circulation 2008, 117:2691-2704.
11. Multiple risk factor intervention trial: risk factor changes mortality results. JAMA 1982, 248:1465-1477.
12. Chobanian AV, Bakris GL, Black HR. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252.
13. Muntner P, Krousel-Wood M, Hyre AD. Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines. Hypertension 2009, 53:617-623.
14. Dahlof B, Sever PS, Poulter NR. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCCOT_BPLA): a multicentre randomized controlled trial. Lancet 2005, 366:895-906.
15. Jamerson K, Weber MA, Bakris GL. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008, 359:2417-2428.